CSIMarket
 


Pmv Pharmaceuticals Inc   (PMVP)
Other Ticker:  
 
 

PMVP's Net Income Growth by Quarter and Year

Pmv Pharmaceuticals Inc 's Net Income results by quarter and year




PMVP Net Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -19.35 -18.36 8.76
III Quarter September -16.64 -18.23 -15.01 -8.76
II Quarter June -17.44 -17.31 -12.87 0.00
I Quarter March -19.13 -18.43 -11.60 0.00
FY   -53.21 -73.32 -57.84 0.00



PMVP Net Income third quarter 2023 Y/Y Growth Comment
Pmv Pharmaceuticals Inc in the third quarter 2023 recorded net loss of $ -16.64 millions.

According to the results reported in the third quarter 2023, Pmv Pharmaceuticals Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Pmv Pharmaceuticals Inc ' s Net Income no change of % ranks overall at the positon no. in the third quarter 2023.




PMVP Net Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Pmv Pharmaceuticals Inc 's third quarter 2023 Net Income $ -16.64 millions PMVP's Income Statement
Pmv Pharmaceuticals Inc 's third quarter 2022 Net Income $ -18.23 millions Quarterly PMVP's Income Statement
New: More PMVP's historic Net Income Growth >>


PMVP Net Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Pmv Pharmaceuticals Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PMVP's III. Quarter Q/Q Net Income Comment
Despite the fact, that Pmv Pharmaceuticals Inc in the III. Quarter 2023 revealed net loss of $ -16.64 millions, some analyst said, that those numbers show recovery compare to the -17.44 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Pmv Pharmaceuticals Inc achieved highest sequential Net Income growth. While Pmv Pharmaceuticals Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PMVP's III. Quarter Q/Q Net Income Comment
Despite the fact, that Pmv Pharmaceuticals Inc in the III. Quarter 2023 admitted net loss of $ -16.64 millions, some analyst point out, that this point to slight up side in contrast to the -17.44 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Pmv Pharmaceuticals Inc achieved highest sequential Net Income growth. While Pmv Pharmaceuticals Inc 's Net Income growth quarter on quarter, overall rank is .


Pmv Pharmaceuticals Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Net Income 12 Months Ending $ -72.55 $ -74.14 $ -74.01 $ -73.32 $ -72.33
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Pmv Pharmaceuticals Inc ' has realized cumulative trailing twelve months net loss of $ -73 millions in the Sep 30 2023 period.

Pmv Pharmaceuticals Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Pmv Pharmaceuticals Inc ' has realized cumulative trailing twelve months net loss of $ -73 millions in the Sep 30 2023 period.

Pmv Pharmaceuticals Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
PMVP's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for PMVP's Competitors
Net Income Growth for Pmv Pharmaceuticals Inc 's Suppliers
Net Income Growth for PMVP's Customers

You may also want to know
PMVP's Annual Growth Rates PMVP's Profitability Ratios PMVP's Asset Turnover Ratio PMVP's Dividend Growth
PMVP's Roe PMVP's Valuation Ratios PMVP's Financial Strength Ratios PMVP's Dividend Payout Ratio
PMVP's Roa PMVP's Inventory Turnover Ratio PMVP's Growth Rates PMVP's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2023
Shockwave Medical Inc -0.05%$ -0.049 millions
Xeris Biopharma Holdings Inc -0.29%$ -0.295 millions
Tenet Healthcare Corp-0.75%$ -0.746 millions
U S Physical Therapy Inc-4.67%$ -4.672 millions
Universal Health Services Inc -4.98%$ -4.979 millions
National Research Corporation-5.09%$ -5.086 millions
Hca Healthcare Inc -5.13%$ -5.134 millions
Viatris Inc -6.41%$ -6.407 millions
Pacific Health Care Organization Inc -6.71%$ -6.710 millions
Mettler toledo International Inc -8.60%$ -8.598 millions
Corcept Therapeutics Inc-9.78%$ -9.777 millions
Charles River Laboratories International inc -9.83%$ -9.826 millions
Third Harmonic Bio Inc -10.51%$ -10.506 millions
The Pennant Group Inc -10.65%$ -10.653 millions
Henry Schein Inc-11.73%$ -11.728 millions
Quest Diagnostics Inc-14.13%$ -14.130 millions
Stryker Corp-15.20%$ -15.196 millions
Zimmer Biomet Holdings Inc -16.12%$ -16.117 millions
Amgen Inc -19.27%$ -19.272 millions
Entera Bio Ltd -22.43%$ -22.432 millions
Regeneron Pharmaceuticals Inc -23.40%$ -23.402 millions
Zynex inc -26.25%$ -26.247 millions
Evofem Biosciences Inc -26.26%$ -26.256 millions
Pediatrix Medical Group Inc -30.39%$ -30.386 millions
Tenax Therapeutics Inc -32.39%$ -32.386 millions
Avantor Inc -35.09%$ -35.090 millions
Ufp Technologies Inc -40.15%$ -40.154 millions
Bio techne Corp-43.17%$ -43.173 millions
Royalty Pharma Plc-44.61%$ -44.615 millions
American Shared Hospital Services-46.43%$ -46.429 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com